InsidersTradesSigma
Total declarations
Company
▲ Purchases (6 ops.)
▼ Sales (0 ops.)
Discover the full record of transactions filed by Schacht Oliver, Chairman & CEO. Insider active across 1 companies, notably OPGEN INC. Aggregated, 7 reports have been published. Total volume traded: €58k. The latest transaction was filed on 3 March 2022 (Levée d'options). Regulator: SEC (Form 4). All data is free.
Declarations7 total
038,750 shares0
Common Stock
SEC:0001079973-22-000214:0·
€13,21410,000 shares@ €1.321445.9% of flow
Common Stock
SEC:0001553350-21-001066·
Ideal exit: 15 Aug 2022 (T+270)
€13,21410,000 shares@ €1.321422.9% of flow
Common Stock
SEC:0001553350-21-001066:0·
Ideal exit: 15 Aug 2022 (T+270)
€13,0295,000 shares@ €2.605845.2% of flow
Common Stock
SEC:0001079973-21-000916·
Ideal exit: 12 Jun 2022 (T+270)
€13,0295,000 shares@ €2.605822.6% of flow
Common Stock
SEC:0001079973-21-000916:0·
Ideal exit: 12 Jun 2022 (T+270)
€2,5531,400 shares@ €1.82388.9% of flow
Common Stock
SEC:0001079973-21-000524·
Ideal exit: 7 Mar 2022 (T+270)
€2,5531,400 shares@ €1.82384.4% of flow
Common Stock
SEC:0001079973-21-000524:0·
Ideal exit: 7 Mar 2022 (T+270)
7 of 7 declarations
About Schacht Oliver
Oliver Schacht is the Chief Executive Officer of OPGEN INC. He leads the company with a strategic vision focused on innovation and growth. Under his leadership, OPGEN INC. strives to develop advanced solutions in the healthcare sector. Oliver Schacht is recognized for his ability to navigate complex environments and make informed decisions that promote the long-term success of the company.
